IsoPlexis Corp
ISODelisted Mar 21, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001615055
IsoPlexis Corp was delisted on Mar 21, 2023; its insiders filed their last Form 4 on Mar 21, 2023; 30 institutions reported holding it in 13F filings for Q4 2022, worth $28.3M in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:43 PM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 |
|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K |
| Reported | Jan 12, 2023 | Jan 10, 2022 |
| Revenue | $16.8M | $17.3M |
| Gross profit | -$925.0K | $8.77M |
| Operating expenses | $100.3M | $85.1M |
| Research and development | $23.5M | $21.0M |
| Selling, general and administrative | $42.7M | $26.3M |
| Operating income | -$101.2M | -$76.3M |
| Net income | -$106.0M | -$81.6M |
| EPS, basic | $-2.70 | $-8.99 |
| EPS, diluted | $-2.70 | $-8.99 |
| Weighted shares, basic | 39.3M | 10.2M |
| Weighted shares, diluted | 39.3M | 10.2M |
| Margins and growth | ||
| Gross margin | -5.5% | 50.8% |
| Operating margin | -604.0% | -442.2% |
| Net margin | -632.4% | -472.6% |
| Revenue growth, year over year | −2.9% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 |
|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K |
| Reported | Jan 12, 2023 | Jan 10, 2022 |
| Cash and equivalents | $37.5M | $126.6M |
| Accounts receivable | $4.50M | $4.10M |
| Inventory | $27.5M | $24.3M |
| Total current assets | $71.9M | $158.4M |
| Property, plant and equipment | $11.2M | $5.78M |
| Intangible assets | $19.8M | $21.0M |
| Total assets | $109.1M | $187.5M |
| Accounts payable | $2.78M | $4.84M |
| Total current liabilities | $17.7M | $13.6M |
| Long-term debt | $46.4M | $31.6M |
| Total liabilities | $67.8M | $45.2M |
| Shareholders' equity | $41.3M | $142.2M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2022 | FY2021 |
|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K |
| Reported | Jan 12, 2023 | Jan 10, 2022 |
| Operating cash flow | -$96.6M | -$86.5M |
| Capital expenditures | $7.36M | $3.80M |
| Free cash flow | -$104.0M | -$90.3M |
| Depreciation and amortization | $3.53M | $2.31M |
| Stock-based compensation | $4.39M | $2.08M |
| Investing cash flow | -$7.82M | -$24.2M |
| Financing cash flow | $15.3M | $130.7M |
| Net change in cash | -$89.1M | – |
| Ratio | ||
| Stock-based compensation, % of revenue | 26.2% | 12.1% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.